Rabies antibody levels in bat handlers in the United Kingdom: Immune response before and after purified chick embryo cell rabies booster vaccination

Human Vaccines

Volumn 3, Issue 5, 2007, Pages 165-170

  Morris, Jill ^a   Crowcroft, Natasha S ^a   Fooks, Anthony R ^b   Brookes, Sharon M ^b   Andrews, Nick ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Bat workers; Booster vaccination; Cross sectional survey; Rabies vaccination; Serology

Indexed keywords

ANTIBODY; RABIES VACCINE;

ADOLESCENT; ADULT; AGED; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BAT; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; OCCUPATIONAL EXPOSURE; RABIES; SEROLOGY; UNITED KINGDOM; VACCINATION; WORKER;

EID: 35348989186     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.3.5.4216     Document Type: Article

References (17)

1. WHO Expert Consultation on Rabies. First Report. Geneva: World Health Organization, 2004, (WHO technical report series; 931).
2. Fooks AR, Brookes SM, Johnson N, McElhinney LM, Hutson AM. European bat lyssaviruses: An emerging zoonosis. Epidemiol Infect 2003; 131:1029-39.
3. Botvinkin AD, Selnikova OP, Antonova LA, Moiseeva AV, Nesterenko EYU. Human Rabies case caused from a bat bite in Ukraine. Rabies Bulletin Europe 2005; 29:5-7.
4. Nathwani D, McIntyre PG, White K, Shearer AJ, Reynolds N, Walker D, Orange GV, Fooks AR. Fatal human rabies caused by European Bat Lyssavirus Type 2a infection in Scotland. Clin Infect Dis 2003; 37:598-601.
5. Department of Health. Rabies, bar handlers and vaccination. Deputy Chief Medical Officer lerter 20 November 2002.
6. Department of Health. Rabies. Immunisation against infectious disease 1996-"The Green Book". Updated May 2005, (Available at http://www.dh.gov.uk/asset-Root/04/11/09/70/04110970.pdf [Accessed 2nd September 2005]).
7. Morris J, Crowcroft NS. Preexposure rabies booster vaccinations: A literature review. Dev Biol 2006; 125:205-15.
8. Cliquet F, Aubert M, Sagne L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Methods 1998; 212:79-87.
9. Strady A, Lang J, Lienard M, Blondeau C, Jaussaud R, Plotkin SA. Antibody persistence following preexposure regimens of cell-culture rabies vaccines: 10-year follow-up and proposal for a new booster policy. J Infect Dis 1998; 177:1290-5.
10. Lang J, Cetre JC, Picot N, Lanta M, Briantais P, Vital S, Le Mener V, Lutsch C, Rotivel Y. Immunogenicity and safety in adults of a new chromatographically purified Vero-cell rabies vaccine (CPRV): A randomised, double-blind trial with purified Vero-cell rabies vaccine (PVRV). Biologicals 1998; 26:299-308.
11. Klietmann W, Klietmann B, Cox J, Charbonnier C. Effectiveness and tolerance of pre and postexposure treatment with purified inactivated rabies vaccine prepared on Vero cell line. Vaccine 1988; 6:39-43.
12. Briggs DJ, Dreesen DW, Morgan P, Chin JE, Seedle CD, Cryz L. Safety and immunogenicity of Lyssavac Berna human diploid cell rabies vaccine in healthy adults. Vaccine 1996; 14:1361-5.
13. Sabchareon A, Lang J, Attanath P, Sirivichayakul C, Pengsaa K, Le Mener V, Chantavanich P, Prarinyanuphab V, Pojjaroen-Anant C, Nimnual S, Wood SC, Riffard P. A new Vero cell rabies vaccine: Results of a comparative trial with human diploid cell rabies vaccine in children. Clin Infect Dis 1999; 29:141-9.
14. Sabchareon A, Chantavanich P, Pasuralertsakul S, Pojjaroen-Anant C, Prarinyanupharb V, Attanath P, Singhasivanon V, Buppodom W, Lang J. Persistence of antibodies in children after intradermal or intramuscular administration of preexposure primary and booster immunisations with purified Vero cell rabies vaccine. Pediatr Infect Dis J 1998; 17:1001-7.
15. Dreesen DW, Fishbein DB, Kemp DT, Brown J. Two-year comparative trial on the immunogenicity and adverse effecrs of purified chick embryo cell rabies vaccine for preexposure immunisation. Vaccine 1989; 7:397-400.
16. Bernard KW, Mallonee J, Wright JC, Reid FL, Makintubee S, Parker RA, Dwyer DM, Winkler WG. Preexposure immunisation with intradermal human diploid cell rabies vaccine. Risks and benefits of primary and booster vaccination. JAMA 1987; 257:1059-63.
17. Brookes SM, Parsons G, Johnson N, McElhinney LM, Fooks AR. Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses. Vaccine 2005; 23:4101-9.